TERF2 and melanoma: After sixteen hours of cycloheximide treatment, TRF2 expression was only slightly decreased in cell lines with constitutive ERK1/2 activity (A375 and SKMel-51 melanoma cells with BRAFV600E mutation and BJ-HELT RAS, Figure 4A and 4B).